ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Qualigen Therapeutics Inc

Qualigen Therapeutics Inc (QLGN)

4,25
-0,09
(-2,07%)
Geschlossen 26 Januar 10:00PM
4,25
0,00
(0,00%)
Nach Börsenschluss: 10:00PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
4,25
Gebot
4,12
Fragen
4,63
Volumen
86.271
4,25 Tagesbereich 4,58
3,3358 52-Wochen-Bereich 29,435
Marktkapitalisierung
Handelsende
4,34
Handelsbeginn
4,50
Letzte Trade
20
@
4.47
Letzter Handelszeitpunkt
Finanzvolumen
US$ 385.634
VWAP
4,47
Durchschnittliches Volumen (3 Mio.)
220.732
Ausgegebene Aktien
736.431
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,02
Gewinn pro Aktie (EPS)
-18,22
Erlöse
-
Nettogewinn
-13,42M

Über Qualigen Therapeutics Inc

Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology. Qualigen Therapeutics Inc is a biotechnology company focused on the development and commercialization of novel therapeutic products for the treatment of cancer and infectious diseases using nanoparticle coating technology.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Qualigen Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker QLGN. The last closing price for Qualigen Therapeutics was US$4,34. Over the last year, Qualigen Therapeutics shares have traded in a share price range of US$ 3,3358 to US$ 29,435.

Qualigen Therapeutics currently has 736.431 shares in issue. The market capitalisation of Qualigen Therapeutics is US$3,20 million. Qualigen Therapeutics has a price to earnings ratio (PE ratio) of -0.02.

QLGN Neueste Nachrichten

Qualigen Therapeutics Announces Regained Compliance with Nasdaq's Minimum Bid Price Requirement and the Equity Requirement

Carlsbad, CA, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics (NASDAQ: QLGN) (the “Company” or “Qualigen”) today announced that the Company received formal notice from The Nasdaq Stock...

Univest Securities, LLC Announces Successful Closing of $5.1 Million Private Placement for Qualigen Therapeutics, Inc. (NASDAQ: QLGN)

New York, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Univest Securities, LLC (“Univest”), a member of FINRA and SIPC, and a full-service investment bank and securities broker-dealer firm based in New...

Qualigen Therapeutics Announces $4.5 Million Private Placement of Convertible Preferred Shares

Carlsbad, CA, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), Qualigen Therapeutics, Inc., is a life science company focused on...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.235.721393034834.024.334.0001105324.1734191CS
4-0.07-1.620370370374.324.673.9195034.25331248CS
12-0.75-1555.9653.33582207324.88294704CS
26-8.1-65.587044534412.3513.53.335815518126.20015271CS
52-20.4-82.758620689724.6529.4353.3358395792515.52510155CS
156-450.75-99.06593406594557603.3358150269150.19679788CS
260-3620.75-99.8827586207362539503.33581780933662.36431787CS

QLGN - Frequently Asked Questions (FAQ)

What is the current Qualigen Therapeutics share price?
The current share price of Qualigen Therapeutics is US$ 4,25
How many Qualigen Therapeutics shares are in issue?
Qualigen Therapeutics has 736.431 shares in issue
What is the market cap of Qualigen Therapeutics?
The market capitalisation of Qualigen Therapeutics is USD 3,2M
What is the 1 year trading range for Qualigen Therapeutics share price?
Qualigen Therapeutics has traded in the range of US$ 3,3358 to US$ 29,435 during the past year
What is the PE ratio of Qualigen Therapeutics?
The price to earnings ratio of Qualigen Therapeutics is -0,02
What is the reporting currency for Qualigen Therapeutics?
Qualigen Therapeutics reports financial results in USD
What is the latest annual profit for Qualigen Therapeutics?
The latest annual profit of Qualigen Therapeutics is USD -13,42M
What is the registered address of Qualigen Therapeutics?
The registered address for Qualigen Therapeutics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Qualigen Therapeutics website address?
The website address for Qualigen Therapeutics is www.qualigeninc.com
Which industry sector does Qualigen Therapeutics operate in?
Qualigen Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
EVAXEvaxion Biotech AS
US$ 5,99
(64,56%)
55,41M
ELABPMGC Holdings Inc
US$ 3,0901
(56,07%)
76,48M
PCLAPicoCELA Inc
US$ 4,60
(49,35%)
3,75M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
GODNUGolden Star Acquisition Corporation
US$ 3,11
(-75,82%)
17,51k
GODNGolden Star Acquisition Corporation
US$ 2,93
(-65,67%)
902,76k
NXTTNext Technology Holding Inc
US$ 1,37
(-54,93%)
2,56M
SGLYSingularity Future Technology Ltd
US$ 1,625
(-38,45%)
917,77k
WHLRLWheeler Real Estate Investment Trust Inc
US$ 90,11
(-38,07%)
8
ACONAclarion Inc
US$ 0,0557
(28,94%)
811,91M
NVNINVNI Group Ltd
US$ 4,38
(193,96%)
366,98M
RIMEAlgorhythm Holdings Inc
US$ 0,0357
(4,69%)
284,97M
GOEVCanoo Inc
US$ 0,475
(43,94%)
282,22M
NVDANVIDIA Corporation
US$ 142,62
(-3,12%)
232,88M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock